v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities    
Net loss $ (3,509) $ (3,438)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation and amortization 5,962 6,488
Equity-based compensation 1,471 2,591
Non-cash interest expense; amortization of debt costs 273 242
Loss on impairment of long-lived assets 0 108
Changes in assets and liabilities    
Taxes receivable (863) 1,251
Prepaid expense and other current assets (1,026) (591)
Other assets 370 4,918
Accounts payable 1,903 (1,461)
Deferred revenue and patient deposits 1,277 (48)
Accrued and other liabilities (1,825) (4,208)
Net cash provided by operating activities 4,033 5,852
Cash flows from investing activities    
Purchases of property and equipment, net (279) (2,166)
Net cash used in investing activities (279) (2,166)
Cash flows from financing activities    
Payments on term loans (12,750) (11,973)
Payments for debt modification 0 (237)
Payments on revolving credit facility 0 (5,000)
Proceeds from public offerings, net 19,566 14,008
Payment of taxes withheld through vested equity-based compensation (195) (56)
Other financing activity 0 (474)
Net cash provided by/(used in) financing activities 6,621 (3,732)
Net increase/(decrease) in cash and cash equivalents 10,375 (46)
Cash and cash equivalents    
Beginning of period 8,449 8,235
End of period 18,824 8,189
Supplemental disclosure of cash flow information:    
Cash paid for interest 2,044 2,948
Cash paid for income taxes, net of refunds 61  
Cash paid for income taxes, net of refunds   (1,777)
Supplemental disclosure of non-cash investing information:    
Property and equipment included in accounts payable and accrued expenses $ 12 $ 137